Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Iron-Chelating Activity of Tetracyclines and Its Impact on the Susceptibility of Actinobacillus actinomycetemcomitansto These Antibiotics

Daniel Grenier, Marie-Pierre Huot, Denis Mayrand
Daniel Grenier
Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Pierre Huot
Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Mayrand
and Faculté des Sciences et de Génie, UniversitéLaval, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.3.763-766.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Three tetracyclines (tetracycline, doxycycline, and minocycline) were found to possess iron-chelating activity in a colorimetric siderophore assay. Determination of MICs indicated that the activity of doxycycline against the periodontopathogen Actinobacillus actinomycetemcomitans was only slightly influenced by the presence of an excess of iron that likely saturates the antibiotic. On the other hand, the MICs of doxycycline and minocycline were significantly lower for A. actinomycetemcomitans cultivated under iron-poor conditions than under iron-rich conditions.

Actinobacillus actinomycetemcomitans is a gram-negative bacterial species which has been associated with periodontal diseases, especially with localized juvenile periodontitis (10, 12). Several studies have shown that tetracyclines are active against A. actinomycetemcomitans (15, 17, 23). Tetracyclines are extensively used as adjuncts in the treatment of periodontitis, a disease affecting the tooth-supporting tissues (gingiva, periodontal ligament, and alveolar bone) and resulting in tooth loss (21, 23). The beneficial effect of tetracyclines relates to three distinctive characteristics: (i) efficiency in suppressing growth of periodontopathogenic gram-negative anaerobic bacteria, (ii) capacity to reach high concentrations in the gingival crevicular fluid, and (iii) capacity to extend their antimicrobial effect by binding to the tooth surface and being slowly released in the periodontal pocket in an active form (23). However, the effectiveness of this group of antibiotics in periodontal therapy may be due not only to its bacteriostatic nature but also to additional nonantimicrobial properties. Indeed, previous studies have shown the capacity of tetracyclines to inhibit matrix metalloproteinase activity as well as bone resorption and to stimulate fibroblast attachment to the radicular surface (6, 7, 23).

Iron is an essential nutrient for most bacteria and therefore is an important factor in the establishment of infections (2, 18, 29). In order to have sufficient iron to survive and to multiply, pathogenic bacteria have developed several strategies to obtain this element (18, 27, 29). While screening a number of molecules for the presence of iron-chelating (siderophore) activity, we found that members of the tetracycline family could strongly chelate iron. The presence of this activity in tetracyclines suggests that these drugs may complex iron in the bacterial environment and create bacteriostatic conditions. This property may thus contribute to the antimicrobial activity of the molecule. The aims of the study were to (i) characterize the iron-chelating activity of three tetracyclines (tetracycline, doxycycline, and minocycline), (ii) evaluate the antibacterial activity of doxycycline under a condition of iron excess that likely saturates the antibiotic molecule, and (iii) determine the MICs of doxycycline and minocycline for A. actinomycetemcomitans cultivated under either poor or rich iron conditions.

The following antibiotics were used: tetracycline hydrochloride, doxycycline hydrochloride, minocycline hydrochloride, penicillin G, gentamicin, clindamycin, spiramycin, and metronidazole (Sigma Chemical Co., St. Louis, Mo.). A. actinomycetemcomitans Y4 and ATCC 29522 were routinely cultivated in an anaerobic chamber (N2-H2-CO2, 80:10:10) at 37°C in Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.) containing 1% yeast extract (THB-YE).

The universal siderophore assay of Schwyn and Neilands (22) was used to measure the iron-chelating activity of the antibiotics. Ferrichrome (Sigma Chemical Co.), a siderophore produced byUstilago sphaerogena (4), was used as the positive control. The ability of tetracyclines, penicillin G, and metronidazole to remove iron from human holotransferrin was determined by urea-borate-EDTA–polyacrylamide gel electrophoresis (PAGE) analysis (11). This electrophoretic procedure allows the distinction of transferrin as apotransferrin (iron-free form), holotransferrin (diferric form), or the monomeric form, in which the iron is associated with either the N- or C-domain binding site. Two colorimetric assays were performed to detect chemical groups known to possess the iron-chelating property in microbial siderophores. The Arnow assay (1) was used to detect the presence of catechol-phenolate-like groups in the three tetracyclines, and 2,3-dihydroxybenzoic acid was used as a positive control. The presence of hydroxamate-like groups was determined by the Csaky procedure (3), and hydroxylamine hydrochloride served as a positive control. Both assays were performed in triplicate and the mean ± standard deviation was calculated.

To evaluate the effect of an excess of iron on the antibacterial activity of doxycycline, the MICs for A. actinomycetemcomitans Y4 and ATCC 29522 were determined in three different media: (i) THB-YE, (ii) THB-YE supplemented with 100 μM FeSO4 (Fe3+ form), and (iii) THB-YE supplemented with 100 μM FeCl3 (Fe2+ form). Doxycycline was dissolved in each medium and twofold serially diluted in order to obtain concentrations ranging from 50 to 0.098 μg/ml. These media were inoculated with a 24-h culture of A. actinomycetemcomitans in THB-YE and incubated at 37°C for 48 h in an anaerobic chamber, and optical densities were measured at 660 nm. The MIC was defined as the lowest concentration of doxycycline at which no bacterial growth occurred. All experiments were performed in duplicate.

The susceptibility to doxycycline and minocycline of A. actinomycetemcomitans ATCC 29522 cultivated under either poor or rich iron conditions was determined using the Epsilometer test (E-test) (AB Biodisk, Solna, Sweden). FeCl3 and FeSO4 were used as iron sources. The tests were performed on THB-YE solid media containing 250 μM 2,2′-dipyridyl and supplemented with either 1, 5, or 50 μM FeCl3 or FeSO4. 2,2′-Dipyridyl was added as an iron-chelating agent to scavenge the iron initially present in the medium. Agar plates were inoculated with a sterile cotton-tipped swab dipped into a 24-h culture of A. actinomycetemcomitans in THB-YE adjusted to the turbidity standard of McFarland 1. One E-test strip, either doxycycline or minocycline, was applied in the center of each inoculated plate so as to visualize the interpretation scale. The E-test plates were incubated until visible bacterial growth was observed (3 to 5 days). The MIC was read at the intersection of the bottom of the elliptic inhibition zone with the E-test strip. All experiments were performed in duplicate.

A strong iron-chelating activity for doxycycline and minocycline and a less pronounced one for tetracycline were detected using a siderophore colorimetric assay (Fig. 1). Ferrichrome, the positive control, reduced the initial absorbance by approximately 50% when used at a concentration of 25 μg/ml, while doxycycline and minocycline reached a comparable decrease at 250 μg/ml and tetracycline reached a comparable decrease at a concentration of >1,000 μg/ml. Penicillin G, gentamicin, clindamycin, spiramycin, and metronidazole did not show any iron-chelating activity (Fig. 1 and data not shown). Incubation of tetracycline, doxycycline, or minocycline with holotransferrin resulted in a complete removal of iron from the molecule, as determined by urea-borate-EDTA–PAGE analysis (Fig.2). No such phenomenon was observed with metronidazole or penicillin. This electrophoretic procedure confirmed the iron-chelating activity of tetracyclines determined by the colorimetric assay. Tetracycline, doxycycline, and minocycline were further analyzed in assays aimed at determining the presence of either hydroxamate-like or catechol-phenolate-like groups, which are known to chelate iron and are usually found in microbial siderophores (Table 1). Results suggested the presence of hydroxamate-like groups in all three tetracyclines and catechol-phenolate-like groups in minocycline.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Iron-chelating activity of ferrichrome and different antibiotics as determined by the chrome azurol sulfate colorimetric assay. Reduction of A650 was measured for various concentrations of the compounds. This reduction occurs when a strong chelator removes the iron from the dye chrome azurol sulfate.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Urea-borate-EDTA–PAGE analysis of human holotransferrin incubated with different antibiotics. Lane 1, control holotransferrin; lane 2, control apotransferrin; lane 3, holotransferrin and tetracycline; lane 4, holotransferrin and doxycycline; lane 5, holotransferrin and minocycline; lane 6, holotransferrin and penicillin G; lane 7, holotransferrin and metronidazole. The upper and lower arrowheads indicate the apotransferrin (iron-free form) and the holotransferrin (iron-saturated form), respectively. Assay mixtures consisted of antibiotics (50 μg/ml; 50 μl) incubated at room temperature with holotransferrin (1 mg/ml in 100 mM phosphate-buffered saline pH 7.2; 50 μl).

View this table:
  • View inline
  • View popup
Table 1.

Detection in tetracycline, doxycycline, and minocycline of catechol-phenolate-like and hydroxamate-like groups

The broth dilution method was used to determine the MICs of doxycycline for A. actinomycetemcomitans in media containing iron in excess (100 μM FeSO4 or 100 μM FeCl3) and in a control medium not supplemented with iron. The MICs of doxycycline for A. actinomycetemcomitans Y4 in THB supplemented with either FeSO4 or FeCl3 were twofold higher (0.78 μg/ml instead of 0.39 μg/ml) than the ones obtained in THB-YE with no iron supplement. However, this phenomenon was not observed with the strain ATCC 29522. Similar data were obtained in two independent experiments.

Table 2 reports the susceptibility to doxycycline and minocycline of A. actinomycetemcomitans ATCC 29522 cultivated under either poor or rich iron conditions as determined by the E-test. When no iron was added to THB-YE containing 2,2′-dipyridyl, no bacterial growth occurred. The MICs of both doxycycline and minocycline were found to be the lowest when A. actinomycetemcomitans was cultivated in a medium with an iron concentration of 1 μM. The MICs became higher as the concentration of iron was increased. For instance, the MIC of doxycycline for A. actinomycetemcomitans grown in the presence of 1 μM FeSO4 was 0.094 μg/ml, whereas it was 0.5 μg/ml in the presence of 50 μM FeSO4. A similar tendency was observed with FeCl3 as the iron supplement. These observations were reproducible.

View this table:
  • View inline
  • View popup
Table 2.

Susceptibility to doxycycline and minocycline ofA. actinomycetemcomitans ATCC 29522 cultivated under either poor or rich iron conditions

In this study, we showed that tetracyclines possess a strong iron-chelating activity. This property appears to be unique, since none of the other antibiotics tested showed this capacity to chelate iron. Previous reports have indicated that tetracyclines form complexes with metallic cations, including iron (20, 25, 26). A number of studies have also revealed that tetracyclines possess a strong capacity to inhibit the activity of matrix metalloproteinases (MMPs) (5, 8, 9). This inhibition appeared to be related to a chelating property, since it could be reversed by the presence of an excess of calcium. It is possible that the same portion of the tetracycline molecule could be responsible for the binding of both calcium and iron. The iron-chelating activity of tetracyclines could also regulate MMP activity by chelating iron and other transition metals present in trace amounts in inflamed periodontal tissues. In fact, the generation of reactive oxygen species, which activate MMPs and induce tissue breakdown, may be prevented by this chelating activity (19, 28).

The low concentration of free iron in the human body constitutes a limiting factor for invading pathogenic bacteria by creating bacteriostatic conditions (2, 18). As for iron in the periodontal pocket, little is known about its exact sources and concentration during periodontitis. However, it has been reported that the concentration of total iron in human gingival crevicular fluid is often higher than in serum (16). The concentration of iron in gingival crevicular fluid is increased significantly in periodontally diseased sites and has been reported to be in the range of 26 to 170 μM (16, 24). In this study, it was found that the activity of doxycycline against A. actinomycetemcomitansY4 was only slightly reduced in the presence of an excess of iron, whereas no differences were noted with the second strain (ATCC 29522). Thus, the interaction between iron and tetracycline appears not to affect strongly the antibacterial activity of the molecule. This finding is in agreement with the results obtained in an animal model by Miles and Maskell (13, 14), who concluded that the complexing of tetracycline with iron did not affect the efficacy of tetracycline but that the efficacy of iron as an enhancer of infection was substantially diminished. Lastly, our study indicated that a much lower concentration of doxycycline or minocycline is required to inhibit growth of A. actinomycetemcomitans in an iron-restricted environment than in an iron-rich environment. It is proposed that the antibiotic could bind either Fe2+ or Fe3+ and make less iron available to bacteria. Under this iron-limiting condition, a lower concentration of the antibiotic would be required to inhibit cell growth. This suggests that the iron-chelating activity of tetracyclines may participate in their antimicrobial action.

ACKNOWLEDGMENTS

This work was supported by the Fonds Émile-Beaulieu. M.-P. Huot was a recipient of a Burroughs Wellcome studentship.

FOOTNOTES

    • Received 24 June 1999.
    • Returned for modification 1 October 1999.
    • Accepted 30 November 1999.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Arnow L. E.
    Colorimetric determination of the compounds of 3,4-dihydroxyphenylalanine-tyrosine mixture. J. Biol. Chem. 118 1937 531 537
    OpenUrlFREE Full Text
  2. 2.↵
    1. Boelaert J. R.
    Iron and infection. Acta Clin. Belg. 51 1996 213 220
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Csaky T. Z.
    On the estimation of bound hydroxylamine in biological materials. Acta Chem. Scand. 2 1948 450 454
    OpenUrlCrossRef
  4. 4.↵
    1. Emery T.
    Role of ferrichrome as a ferric ionophore in Ustilago sphaerogena. Biochemistry 10 1971 1483 1488
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Golub L. M.,
    2. Lee H. M.,
    3. Lehrer G.,
    4. Nemiroff A.,
    5. McNamara T. F.,
    6. Kaplan R.,
    7. Ramamurthy N. S.
    Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J. Periodontal Res. 18 1983 516 526
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Golub L. M.,
    2. Ramamurthy N. S.,
    3. McNamara T. F.,
    4. Greenwald R. A.,
    5. Rifkin B. R.
    Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 2 1991 297 322
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Golub L. M.,
    2. Wolff M.,
    3. Roberts S.,
    4. Lee H. M.,
    5. Leung M.,
    6. Payonk G. S.
    Treating periodontal diseases by blocking tissue destructive enzymes. J. Am. Dent. Assoc. 125 1994 163 171
    OpenUrlAbstract
  8. 8.↵
    1. Golub L. M.,
    2. Sorsa T.,
    3. Lee H. M.,
    4. Ciancio S.,
    5. Sorbi D.,
    6. Ramamurthy N.
    Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J. Clin. Periodontol. 21 1995 1 9
    OpenUrl
  9. 9.↵
    1. Greenwald R. A.,
    2. Golub L. M.,
    3. Lavietes B.,
    4. Ramamurthy N. S.,
    5. Guber B.,
    6. Laskin R. S.
    Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J. Rheumatol. 14 1987 28 32
    OpenUrlPubMedWeb of Science
  10. 10.↵
    1. Haffajee A. D.,
    2. Socransky S. S.
    Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000 5 1994 78 111
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Makey D. G.,
    2. Seal U. S.
    The detection of four molecular forms of human transferring during the iron binding process. Biochim. Biophys. Acta 453 1976 250 256
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Meyer D. H.,
    2. Fives-Taylor P. M.
    The role of Actinobacillus actinomycetemcomitans in the pathogenesis of periodontal disease. Trends Microbiol. 5 1997 224 228
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Miles A. A.,
    2. Maskell J. P.
    The antagonism of tetracyclines and ferric iron in vivo. J. Med. Microbiol. 20 1985 17 26
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Miles A. A.,
    2. Maskell J. P.
    The neutralization of antibiotic action by metallic cations and iron chelators. J. Antimicrob. Chemother. 17 1986 481 487
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Miyake Y.,
    2. Tsuruda K.,
    3. Okuda K.,
    4. Widomati,
    5. Iwamoto Y.,
    6. Suginaka H.
    In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. J. Periodontal Res. 30 1995 290 293
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Mukherjee S.
    The role of crevicular fluid iron in periodontal disease. J. Periodontol. 56 1985 22 27
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Olsvik B.,
    2. Hansen B. F.,
    3. Tenover F. C.,
    4. Olsen I.
    Tetracycline-resistant microorganisms recovered from patients with refractory periodontal disease. J. Clin. Periodontol. 22 1995 391 396
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Otto B. R.,
    2. Verweij-van Vught A. M. J. J.,
    3. MacLaren D. M.
    Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit. Rev. Microbiol. 18 1992 217 233
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Rajagopalan S.,
    2. Mang X. P.,
    3. Ramasamy S.,
    4. Harrison D. G.,
    5. Galis Z. S.
    Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J. Clin. Investig. 98 1996 2572 2579
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Riaz M.,
    2. Pilpel N.
    Complexation of tetracyclines with metal ions in relation to photosensitization. J. Pharm. Pharmacol. 36 1984 153 156
    OpenUrlPubMed
  21. 21.↵
    1. Rifkin B. R.,
    2. Vernillo A. T.,
    3. Golub L. M.
    Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J. Periodontol. 64 1993 819 827
    OpenUrlPubMedWeb of Science
  22. 22.↵
    1. Schwyn B.,
    2. Neilands J. B.
    Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160 1987 47 56
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Seymour R. A.,
    2. Heasman P. A.
    Tetracyclines in the management of periodontal diseases. J. Clin. Periodontol. 22 1995 22 35
    OpenUrlPubMed
  24. 24.↵
    1. Wang H.-L.,
    2. Greenwell H.,
    3. Bissada N. F.
    Crevicular fluid iron changes in treated and untreated periodontically diseased sites. Oral Surg. Oral Med. Oral Pathol. 69 1990 450 456
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Weinberg E. D.
    The mutual effects of antimicrobial compounds and metallic cations. Bacteriol. Rev. 21 1957 46 68
    OpenUrlFREE Full Text
  26. 26.↵
    1. Weinberg E. D.
    Roles of iron in host-parasite interactions. J. Infect. Dis. 24 1971 401 410
    OpenUrl
  27. 27.↵
    1. Weinberg E. D.
    Acquisition of iron and other nutrients in vivo Virulence mechanisms of bacterial pathogens 2nd ed. Roth J. A., et al. 1995 79 93 American Society for Microbiology Washington, D.C.
  28. 28.↵
    1. Weiss S. J.
    Tissue destruction by neutrophils. N. Engl. J. Med. 320 1989 365 376
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Wooldridge K. G.,
    2. Williams P. H.
    Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol. Rev. 12 1993 325 348
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Iron-Chelating Activity of Tetracyclines and Its Impact on the Susceptibility of Actinobacillus actinomycetemcomitansto These Antibiotics
Daniel Grenier, Marie-Pierre Huot, Denis Mayrand
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 763-766; DOI: 10.1128/AAC.44.3.763-766.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Iron-Chelating Activity of Tetracyclines and Its Impact on the Susceptibility of Actinobacillus actinomycetemcomitansto These Antibiotics
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Iron-Chelating Activity of Tetracyclines and Its Impact on the Susceptibility of Actinobacillus actinomycetemcomitansto These Antibiotics
Daniel Grenier, Marie-Pierre Huot, Denis Mayrand
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 763-766; DOI: 10.1128/AAC.44.3.763-766.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Aggregatibacter actinomycetemcomitans
Anti-Bacterial Agents
iron
Iron Chelating Agents

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596